Filippo Pietrantonio

Research interests

Publications

• Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

  New England Journal of Medicine · 2025 · https://doi.org/10.1056/nejmoa2503119

• NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer

  JAMA Network Open · 2024 · https://doi.org/10.1001/jamanetworkopen.2023.50756

• Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C

  New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2308795

• The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

  British Journal of Cancer · 2020 · https://doi.org/10.1038/s41416-020-0894-7

• Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

  The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(19)30862-9

• Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer

  Nature Medicine · 2020 · https://doi.org/10.1038/s41591-020-0882-8

• Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer

  Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.19.01124

• Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan

  JAMA Oncology · 2018 · https://doi.org/10.1001/jamaoncol.2018.5080

• Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis

  Journal of Gastrointestinal Oncology · 2017 · https://doi.org/10.21037/jgo.2017.01.10

• Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth

  Nature · 2017 · https://doi.org/10.1038/nature24673

• ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer

  JNCI Journal of the National Cancer Institute · 2017 · https://doi.org/10.1093/jnci/djx089

• HER2 loss in HER2‐positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research

  International Journal of Cancer · 2016 · https://doi.org/10.1002/ijc.30408

• Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: A meta-analysis

  European Journal of Cancer · 2015 · https://doi.org/10.1016/j.ejca.2015.01.054

Current projects

No projects listed.